Evidence map›Paper›PMID 29313479›Full record

ArticleThe American journal of tropical medicine and hygiene2018

The Quality of Medicines Used in Children and Supplied by Private Pharmaceutical Wholesalers in Kinshasa, Democratic Republic of Congo: A Prospective Survey.

Benedetta Schiavetti, Evelien Wynendaele, Bart De Spiegeleer, Geremie J Mbinze, Nicodème Kalenda, Roland Marini, Vera Melotte, Epco Hasker, Bruno Meessen, Raffaella Ravinetto and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Perceptions and Acceptability ofHealthcare (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Benedetta SchiavettiDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Evelien WynendaeleDrug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
Bart De SpiegeleerDrug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
Geremie J MbinzeFaculty of Pharmaceutical Sciences, Laboratory of Drug Analysis, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Nicodème KalendaFaculty of Pharmaceutical Sciences, Laboratory of Drug Analysis, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Roland MariniDepartment of Pharmacy, CIRM, Laboratory of Analytical Chemistry, University of Liege (ULg), Liege, Belgium.
Vera MelotteBelgian Technical Cooperation (BTC), Bruxelles, Belgium.
Epco HaskerDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Bruno MeessenDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Raffaella RavinettoDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Josiane Van der ElstBelgian Federal Agency for Medicines and Health Products (FAGG-AFMPS), Bruxelles, Belgium.
Daniel Mutolo NgelekaDirection de la Pharmacie et du Médicament (DPM), Kinshasa, Democratic Republic of Congo.
Instituut voor Tropische Geneeskunde · BEGhent University · BEUniversity of Kinshasa · CDBelgian Development Agency · BEUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poor-quality medicines are a threat to public health in many low- and middle-income countries, and prospective surveys are needed to inform corrective actions. Therefore, we conducted a cross-sectional survey on a sample of products used for children and available in the private market in Kinshasa, Democratic Republic Congo: amoxicillin (AX) and artemether/lumefantrine (AL), powders for suspension, and paracetamol (PC) tablets 500 mg. Overall, 417 products were covertly purchased from 61 wholesalers. To obtain a representative sample, the products were weighted on their market shares and a subset of 239 samples was randomly extracted to undergo in-depth visual inspection locally, and they were chemically assessed at two accredited laboratories in Belgium. Samples were defined of "poor-quality" if they failed to comply with at least one specification of the International Pharmacopoeia (for AL) or United States Pharmacopoeia 37 (for AX and PC). Results are reported according to the Medicine Quality Assessment Reporting Guideline. The visual inspection detected nonconformities in the aspects of antimalarial powders for suspension, and poor-quality labels across all medicine types. According to chemical analysis, 27.2% samples were of poor quality and 59.5% of AL samples were underdosed in artemether. Poor quality was more frequent for locally manufactured antimalarials (83.3%,

Indexed as

Quality ControlAcetaminophenAdultAmoxicillinAnti-Bacterial AgentsAntimalarialsAntipyreticsArtemether, Lumefantrine Drug CombinationChildDemocratic Republic of the CongoHumansPharmaciesPowdersPractice Guidelines as TopicPrivate SectorTabletsAcetaminophenAmoxicillinAnti-Bacterial AgentsAntimalarialsAntipyreticsArtemether, Lumefantrine Drug CombinationPowdersTablets

Identifiers

PMID29313479
PMCPMC5930909
OpenAlexW2783530055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.